NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Collections Health Policy and Services Research Remove constraint Collections: Health Policy and Services Research Subjects United States. Food and Drug Administration. Remove constraint Subjects: United States. Food and Drug Administration. Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later Publication Year 2020 to 2021 Remove constraint Publication Year: <span class="from" data-blrl-begin="2020">2020</span> to <span class="to" data-blrl-end="2021">2021</span>

Search Results

72. Importation of certain FDA approved human prescription drugs, including biological products, and combination products under section 801(d)(1)(b) of the Federal Food, Drug, and Cosmetic Act

73. Recognition and withdrawal of voluntary consensus standards: guidance for industry and Food and Drug Administration staff

74. The Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program: guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

75. Basic safety and essential performance of medical electrical equipment, medical electrical systems, and laboratory medical equipment: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

76. Biocompatibility testing of medical devices: standards specific information for the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program : guidance for industry, accreditation bodies, testing laboratories, and Food and Drug Administration staff

78. Breast implants: certain labeling recommendations to improve patient communication : guidance for industry and Food and Drug Administration staff

79. Self-monitoring blood glucose test systems for over-the-counter use: guidance for industry and Food and Drug Administration staff

80. Use of International Standard ISO 10993-1: "Biological evaluation of medical devices - part 1 : evaluation and testing within a risk management process" : guidance for industry and Food and Drug Administration staff